Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients.

Study Overview
=================
Brief Summary
-----------------
To test the effectiveness of a respiratory physiotherapy treatment plan in patients who have passed COVID-19, comparing two randomized groups, for the performance of different respiratory musculature training protocols. To objectify the results data obtained by means of ultrasound measurements and spirometry, observing the differences obtained at the beginning and end of the study, verifying the effectiveness of the PowerBreathe® ,Therosold PEP® tools and the effectiveness of diaphragmatic, abdominal and expiratory exercises.

Official Title
-----------------
Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients. Randomiced Clinical Trial

Conditions
-----------------
COVID-19, Respiratory Distress Syndrome

Intervention / Treatment
-----------------
* Device: PowerBreathe and PEP Therosold tools


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients diagnosed with Covid and suffering from functional limitations in the respiratory system. Patients over 18 years of age. Patients under 65 years of age. Patientes with cognitive ability to perform spirometry. Patients with the physical capacity to perform spirometry Exclusion Criteria: - Patients diagnosed with Covid and without functional limitations in the respiratory system. Patients under 18 years of age. Patients over 65 years of age. Patients without cognitive capacity to perform spirometry. Patients without physical capacity to perform spirometry.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: the PowerBreathe and PEP Therosold tools group<br> | Device: PowerBreathe and PEP Therosold tools<br>* Initially, the following data were collected from each subject in addition to basic epidemiological data: M-mode diaphragmatic excursion measurements, both in inspiration and expiration via ultrasound; spirometry is also carried out, obtaining values of forced vital capacity (FVC or FVC), forced expiratory volume (FEV), portion of FVC (FEV1/FVC), peak expiratory flow (PEF), mean expiratory flow, peak inspiratory pressure (PIM) and peak expiratory pressure (PEM). A 30-day treatment plan was carried out in which one group (Tool Group) had to perform 5 minutes of exercise with each tool, alternating with one minute of rest between each minute of exercise, starting with the Therosold PEP® and then the PowerBreathe®. The resistances applied to the devices were marked according to the specific assessment of each subject, in relation to the spirometric values of PIM and PEM.<br>|
| Active Comparator: perform diaphragmatic breathing, series of abdominal crunches and expiratory exercises group.<br> | Device: PowerBreathe and PEP Therosold tools<br>* Initially, the following data were collected from each subject in addition to basic epidemiological data: M-mode diaphragmatic excursion measurements, both in inspiration and expiration via ultrasound; spirometry is also carried out, obtaining values of forced vital capacity (FVC or FVC), forced expiratory volume (FEV), portion of FVC (FEV1/FVC), peak expiratory flow (PEF), mean expiratory flow, peak inspiratory pressure (PIM) and peak expiratory pressure (PEM). A 30-day treatment plan was carried out in which one group (Tool Group) had to perform 5 minutes of exercise with each tool, alternating with one minute of rest between each minute of exercise, starting with the Therosold PEP® and then the PowerBreathe®. The resistances applied to the devices were marked according to the specific assessment of each subject, in relation to the spirometric values of PIM and PEM.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| peak inspiratory pressure (PIM) | 0 miminum ,200 maximum | 1 month | 
| peak expiratory pressure | 0 miminum ,200 maximum | 1 month | 
| forced vital capacity | 0 miminum ,200 maximum | 1 month |